Predict your next investment

NeurOptics company logo
Corporation
HEALTHCARE | Medical Devices & Equipment
neuroptics.com

See what CB Insights has to offer

Stage

Debt | Alive

Total Raised

$2.3M

Last Raised

$500K | 6 yrs ago

About NeurOptics

NeurOptics develops medical devices which collect and process information from the human eye to facilitate medical decision making and enable clinical research.

NeurOptics Headquarter Location

18101 Von Karman Ave Suite 1940

Irvine, California, 92612,

United States

949-250-9792

Latest NeurOptics News

NeurOptics Launches New NPi-300 Automated Pupillometer

Sep 28, 2021

NeurOptics Launches New NPi-300 Automated Pupillometer NeurOptics Launches New NPi-300 Automated Pupillometer Automated pupillometry and the Neurological Pupil index emerge as critical tools for assessing patients at risk of brain injury. NeurOptics' NPi-300 is a next-generation automated pupillometer that enhances pupillary assessment to assist in detecting cerebral insult. Business Wire09.28.21 NeurOptics , the worldwide leader in the science of pupillometry, has launched in the United States its NPi-300, a next-generation automated pupillometer that enhances pupillary assessment to assist in detecting cerebral insult, guiding treatment and informing prognosis for clinicians and their patients. Early detection of neurological injury is critical for effective and timely diagnosis and treatment.1 NeurOptics’ quantitative automated pupillometer provides a reliable measurement of pupil size and reactivity and tracks changes over time, allowing for earlier intervention for patients with brain injury and those at risk of secondary neurological injury. The NPi-300 Pupillometer supports neurological examination in adult and pediatric patients across a broad spectrum of diagnoses, including traumatic brain injury, stroke, seizure, or other neurological events after cardiac arrest and other medical conditions. Advanced wireless charging technology, offering improved reliability for the clinician Incorporated barcode scanner, allowing clinicians to easily scan a new patient’s ID accurately and instantaneously Updated graphical user interface, featuring an easy-to-read LCD touchscreen that enhances the visibility of the results screen   “We are excited to launch this advanced, next-generation pupillometer,” said William Worthen, president and CEO, NeurOptics. “It is a pivotal time for pupillometry, as more hospitals, ICUs and emergency departments are adopting the technology to assess patients for changes in pupillary light reflex—a sign of neurological injury. The NPi-300 Pupillometer, along with the Neurological Pupil index (NPi) scale, provides clinicians with the information needed to make better treatment decisions.”   Automated pupillometry has emerged as an important technology that provides a quantitative measurement of pupil size and reactivity, expressed as the Neurological Pupil index (NPi). NPi values range from 0 to 4.9, with scores under 3 considered abnormal. The NeurOptics NPi-300 Pupillometer eliminates the variability and subjectivity inherent in manual pupillary evaluation (performed using a penlight), providing more accurate, reliable, and objective pupil size and reactivity measurement for this vital component of neurological examinations.1-8   Headquartered in Irvine, Calif., NeurOptics is the leader in the science of pupillometry. Driven by a passion to help clinicians improve patient outcomes, NeurOptics develops and markets technology for use in critical care medicine, neurology, neurosurgery, emergency medicine, and research. The NeurOptics’ NPi Pupillometer has been included in more than 70 clinical studies, adopted in over 490 hospitals in the United States, and is represented in more than 27 countries worldwide. References 1 Kerr R, Bacon A, Baker L, et al. Underestimation of pupil size by critical care and neurosurgical nurses. American J of Critical Care. 2016;25(3):213-219. 2 Olson D, Fishel M. The use of automated pupillometry in critical care. Critical Care Nursing Clinics North America. 2015;28(2016):101-107. 3 Meeker M, Du R, Bacchetti P, et al. Pupil examination: validity and clinical utility of an automated pupillometer. J Neurosci Nurs. 2005;37:34–40. 6. 4 Wilson S, Amling J, Floyd S, McNair N. Determining interrater reliability of nurses' assessments of pupillary size and reaction. J Neurosci Nurs. 1988;20:189–192. 5 Litvan I, Saposnik G, Mauriño J, et al. Pupillary diameter assessment: need for a graded scale. Neurology. 2000;54:530–531. 25. 6 Olson D, Stutzman S, Saju C, Wilson M, Zhao W, Aiyagari V. Interrater reliability of pupillary assessments. Neurocritical Care. 2015. 26. 7 Stutzman S, Olson D, Saju C, Wilson M, Aiyagari V. Interrater reliability of pupillar assessments among physicians and nurses. UT Southwestern Medical Center; 2014. 27. 8 Worthley L. The pupillary light reflex in the critically ill patient. Critical Care and Resuscitation. 2000;2(7).

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing NeurOptics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

NeurOptics is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

7,889 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

D

Digital Health

12,248 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

NeurOptics Patents

NeurOptics has filed 22 patents.

The 3 most popular patent topics include:

  • Ophthalmology
  • Diseases of the eye and adnexa
  • G protein coupled receptors
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/8/2012

11/23/2021

Computer buses, Computer art, USB, Serial buses, Dosage forms

Grant

Application Date

7/8/2012

Grant Date

11/23/2021

Title

Related Topics

Computer buses, Computer art, USB, Serial buses, Dosage forms

Status

Grant

NeurOptics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

NeurOptics Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.